First Lyme Disease Vaccine Shows 70% Efficacy in Trials

A new vaccine could soon protect people from Lyme disease for the first time in over 20 years.

Pfizer and Valneva's candidate showed over 70% effectiveness in preventing the tick-borne illness that affects hundreds of thousands annually.